Ferguson Enterprises Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Ferguson Enterprises Inc. Common Stock trades at $222 (market cap $43.11B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Ferguson Enterprises Inc. Common Stock is far larger — about 23.9× Vir Biotechnology Inc. Common Stock's market cap, and Ferguson Enterprises Inc. Common Stock pays a 1.6% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ferguson Enterprises Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| FERG | VIR | |
|---|---|---|
Market Cap | $43.11B | $1.80B |
Volume | 945,793 | 1,782,836 |
Sector | Industrials | Health |
52-Week High | $267.71 | $11.78 |
52-Week Low | $214.26 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $49.56B | $1.36B |
Dividend Yield | 1.6% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ferguson Enterprises, Inc. distributes plumbing, HVAC, waterworks, and related building products to professional contractors, builders, and facility managers across North America, operating through branches, showrooms, and digital commerce.
Read more on FERG →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →